Literature DB >> 18987297

Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.

Steven Fishbane1, Simcha Pollack, Harold I Feldman, Marshall M Joffe.   

Abstract

BACKGROUND AND OBJECTIVES: Anemia is a common and early complication of nondialysis chronic kidney disease (CKD). One contributing factor is iron deficiency, which may be particularly problematic during erythropoietin replacement therapy. The aim of this study was to examine the prevalence of iron deficiency in nondialysis CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The National Health and Nutritional Examination Survey (NHANES) data for NHANES III (1988 to 1994) and subsequent NHANES 2-yr datasets, 1999 to 2000, 2001 to 2002, and 2003 to 2004 were analyzed for individuals >18 yr old.
RESULTS: It was found that low levels of iron tests [either serum ferritin < 100 ng/ml or transferrin saturation (TSAT) < 20%] were present in most patients with reduced creatinine clearance (CrCl). The percentage of low iron tests was higher among women than men, present in 57.8 to 58.8% of men and 69.9 to 72.8% of women (P < 0.001). With declining levels of CrCl, in women, TSAT levels decreased, whereas, surprisingly, serum ferritin tended to progressively increase. The percentage of anemic subjects increased progressively with declining quartiles of TSAT but was unrelated to serum ferritin quartiles.
CONCLUSIONS: It was found that low levels of iron tests, following National Kidney Foundation/Kidney Disease Outcomes Quality Initiative guidelines (either serum ferritin < 100 ng/ml or TSAT < 20%) were present in most patients with reduced CrCl.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987297      PMCID: PMC2615715          DOI: 10.2215/CJN.01670408

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  18 in total

1.  Predicting glomerular function from adjusted serum creatinine.

Authors:  M H Gault; L L Longerich; J D Harnett; C Wesolowski
Journal:  Nephron       Date:  1992       Impact factor: 2.847

2.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

3.  Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey.

Authors:  Chi-Yuan Hsu; Charles E McCulloch; Gary C Curhan
Journal:  J Am Soc Nephrol       Date:  2002-02       Impact factor: 10.121

4.  Iron status in patients receiving erythropoietin for dialysis-associated anemia.

Authors:  D B Van Wyck; J C Stivelman; J Ruiz; L F Kirlin; M A Katz; D A Ogden
Journal:  Kidney Int       Date:  1989-02       Impact factor: 10.612

5.  Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Rudolph A Rodriguez; Michael H Humphreys
Journal:  Nephrol Dial Transplant       Date:  2004-01       Impact factor: 5.992

6.  Studies of the pathogenesis of anemia of inflammation: mechanism of impaired erythropoiesis.

Authors:  D J Weiss; J D Krehbiel; J E Lund
Journal:  Am J Vet Res       Date:  1983-10       Impact factor: 1.156

7.  Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004.

Authors:  Elizabeth Selvin; Jane Manzi; Lesley A Stevens; Frederick Van Lente; David A Lacher; Andrew S Levey; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2007-12       Impact factor: 8.860

8.  Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

Authors:  B Payson Oberg; Elizabeth McMenamin; F Lee Lucas; Ellen McMonagle; Jason Morrow; T Alp Ikizler; Jonathan Himmelfarb
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

9.  Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study.

Authors:  Martin J Landray; David C Wheeler; Gregory Y H Lip; David J Newman; Andrew D Blann; Fiona J McGlynn; Simon Ball; John N Townend; Colin Baigent
Journal:  Am J Kidney Dis       Date:  2004-02       Impact factor: 8.860

10.  Iron status and hemoglobin level in chronic renal insufficiency.

Authors:  Chi-Yuan Hsu; Charles E McCulloch; Gary C Curhan
Journal:  J Am Soc Nephrol       Date:  2002-11       Impact factor: 10.121

View more
  60 in total

1.  Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury.

Authors:  Ali C M Johnson; Kirsten Becker; Richard A Zager
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-26

2.  Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia.

Authors:  Steven Fishbane; Geoffrey A Block; Lisa Loram; John Neylan; Pablo E Pergola; Katrin Uhlig; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2017-01-12       Impact factor: 10.121

3.  A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.

Authors:  Iain C Macdougall; William E Strauss; Justin McLaughlin; Zhu Li; Frank Dellanna; Joachim Hertel
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

4.  Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients.

Authors:  Taehee Kim; Elani Streja; Melissa Soohoo; Connie M Rhee; Rieko Eriguchi; Tae Woo Kim; Tae Ik Chang; Yoshitsugu Obi; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2017-07-14       Impact factor: 3.754

5.  Intravenous Iron Use in the Care of Patients with Kidney Disease.

Authors:  Iain C Macdougall
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-07       Impact factor: 8.237

6.  Anaemia: FIND-CKD: intravenous iron in predialysis CKD.

Authors:  Steven Fishbane; Azzour D Hazzan
Journal:  Nat Rev Nephrol       Date:  2014-08-05       Impact factor: 28.314

7.  Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?

Authors:  Simona Stancu; Liliana Bârsan; Ana Stanciu; Gabriel Mircescu
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 8.237

Review 8.  Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology.

Authors:  Vincenzo Bellizzi; Giuseppe Conte; Silvio Borrelli; Adamasco Cupisti; Luca De Nicola; Biagio R Di Iorio; Gianfranca Cabiddu; Marcora Mandreoli; Ernesto Paoletti; Giorgina B Piccoli; Giuseppe Quintaliani; Maura Ravera; Domenico Santoro; Serena Torraca; Roberto Minutolo
Journal:  J Nephrol       Date:  2016-08-27       Impact factor: 3.902

Review 9.  Anemia, diabetes, and chronic kidney disease.

Authors:  Uzma Mehdi; Robert D Toto
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 17.152

10.  The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study.

Authors:  Adrian Covic; Gabriel Mircescu
Journal:  Nephrol Dial Transplant       Date:  2010-02-26       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.